Natus, a California company that makes diagnostic products for hospitals, said fourth-quarter profit will be less than forecast as orders in the neurology unit are delayed or reduced. Profit may be 15 cents a share, missing July’s outlook of 19 to 20 cents. The delays in orders for products to test for epilepsy and other neurological conditions led to third-quarter revenue that was less than expected.
© Copyright 2011 Globe Newspaper Company.
